淋巴瘤、白血病患者ESOD活性测定

The Erythrocyte Superoxide Dismutase Activities in Patients with Lymphoma, and Leukemia

测定了10例淋巴瘤患者及24例髓性白血病患者外周血红细胞超氧化物歧化酶(ESOD)活性。测定结果:①80％淋巴瘤患者具有ESOD缺陷;②33％白血病患者有ESOD缺陷,而13％具ESOD活性增高。

Erythrocyte superoxide dismutase (ESOD) activities of peripheral blood -were measured in 10 patients with lymphoma, in 24 patients with myelogenous leukemia, and in 30 normal adults. A marked reduction of ESOD activity was found in 80% patients with untreated lymphoma, and in 33% patients with non-remission leukemia, but an increase of ESOD activity was noted in 13% patients with non-remission leukemias. The clinical significance is discussed.